Abstract
No public abstract is available from the verified source records.
Yuheng Wang, Yuanzhi He, Jiayu Xu, Hengjie Su, Jiadi Lv
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Glycolysis inhibition affects proliferation and cytotoxicity of Vγ9Vδ2 T cells expanded for adoptive cell therapy
10.1016/j.jcyt.2024.04.072 · 2024
Delta One T cells for immunotherapy of chronic lymphocytic leukemia: clinical-grade expansion/differentiation and preclinical proof of concept
10.1158/1078-0432.ccr-16-0597 · 2016
Chimeric antigen receptor T cell immunotherapy for autoimmune rheumatic disorders: where are we now?
10.3390/cells14161242 · 2025
bibliometrix: An R-tool for comprehensive science mapping analysis
10.1016/j.joi.2017.08.007 · 2017
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
10.1126/science.285.5428.727 · 1999
Single-cell RNA sequencing of human breast tumour-infiltrating immune cells reveals a γδ T-cell subtype associated with good clinical outcome
10.26508/lsa.202000680 · 2020
Cross-presenting human γδ T cells induce robust CD8+ αβ T cell responses
10.1073/pnas.0810059106 · 2009
Chimeric antigen receptor-engineered human gamma delta T cells: enhanced cytotoxicity with retention of cross presentation
10.1016/j.ymthe.2017.12.001 · 2018
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions
10.1016/j.celrep.2021.109871 · 2021
CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature
10.1002/asi.20317 · 2006
Gammadelta (γδ) T lymphocytes do not impact the development of early atherosclerosis
10.1016/j.atherosclerosis.2014.03.007 · 2014
A cell for the ages: human γδ T cells across the lifespan
10.3390/ijms21238903 · 2020
Unresolved referenced work
Kept as external metadata until matched
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
10.1038/nature14282 · 2015
Ectopically expressed human tumor biomarker MutS homologue 2 is a novel endogenous ligand that is recognized by human γδ T cells to induce innate anti-tumor/virus immunity
10.1074/jbc.m111.327650 · 2012
γδ T cells support pancreatic oncogenesis by restraining αβ T cell activation
10.1016/j.cell.2016.07.046 · 2016
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune response
10.1126/scitranslmed.abj0835 · 2021
Clinical applications of gamma delta T cells with multivalent immunity
10.3389/fimmu.2014.00636 · 2014
Off-the-shelf’ allogeneic CAR T cells: development and challenges
10.1038/s41573-019-0051-2 · 2020
Epithelia use butyrophilin-like molecules to shape organ-specific γδ T cell compartments
10.1016/j.cell.2016.08.030 · 2016
How to conduct a bibliometric analysis: an overview and guidelines
10.1016/j.jbusres.2021.04.070 · 2021
A simple and robust single-step method for CAR-Vδ1 γδT cell expansion and transduction for cancer immunotherapy
10.3389/fimmu.2022.863155 · 2022
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
10.1084/jem.20021500 · 2003
Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells
10.1126/science.279.5357.1737 · 1998
γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs
10.1182/blood-2012-05-432427 · 2012
Current concerns and future directions of large language model ChatGPT in medicine: a machine-learning-driven global-scale bibliometric analysis
10.1097/js9.0000000000003668 · 2026
Artificial intelligence AlphaFold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation
10.1186/s12943-024-02140-6 · 2024
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
10.1182/blood-2012-05-430470 · 2012
γδ T cell update: adaptive orchestrators of immune surveillance
10.4049/jimmunol.1800934 · 2019
TCRγ4δ1-engineered αβT cells exhibit effective antitumor activity
10.2119/molmed.2016.00023 · 2016
Improved survival with ipilimumab in patients with metastatic melanoma
10.1056/nejmoa1003466 · 2010
Unresolved referenced work
Kept as external metadata until matched
Flanking V and J sequences of complementary determining region 3 of T-cell receptor (TCR) δ1 (CDR3δ1) determine the structure and function of TCRγ4δ1
10.1074/jbc.m111.239624 · 2011
Metabolic reprogramming of interleukin-17-producing γδ T cells promotes ACC1-mediated de novo lipogenesis under psoriatic conditions
10.1038/s42255-025-01276-z · 2025
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma
10.1007/s00262-006-0199-6 · 2007
The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D
10.1182/blood-2008-12-196287 · 2009
Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma
10.1182/blood.v96.2.384.013k07_384_392 · 2000
Cutting edge: bispecific γδ T cell engager containing heterodimeric BTN2A1 and BTN3A1 promotes targeted activation of Vγ9Vδ2+ T cells in the presence of costimulation by CD28 or NKG2D
10.4049/jimmunol.2200185 · 2022
Bibliometric methods in management and organization
10.1177/1094428114562629 · doi-reference
γδ T cells: Major advances in basic and clinical research in tumor immunotherapy
10.1097/cm9.0000000000002781 · doi-reference
CDR3δ-grafted γ9δ2T cells mediate effective antitumor reactivity
10.1038/cmi.2011.28 · doi-reference
Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells
10.1038/s41586-023-06525-3 · doi-reference
γδ T-cell autoresponses to ectopic membrane proteins: a new type of pattern recognition
10.1038/s41423-025-01258-x · doi-reference
An innate-like Vδ1+ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer
10.1126/scitranslmed.aax9364 · doi-reference
Lysis of a broad range of epithelial tumour cells by human γδ T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition
10.1111/j.1365-3083.2007.01963.x · doi-reference
Butyrophilin-like 3 directly binds a human Vγ4+ T cell receptor using a modality distinct from clonally-restricted antigen
10.1016/j.immuni.2019.09.006 · doi-reference
γδ T cells for immune therapy of patients with lymphoid malignancies
10.1182/blood-2002-12-3665 · doi-reference
Anti-PD-1 antibody armored γδ T cells enhance anti-tumor efficacy in ovarian cancer
10.1038/s41392-023-01646-7 · doi-reference
A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia
10.1016/j.clml.2023.02.003 · doi-reference
γδT cells are prevalent in the proximal aorta and drive nascent atherosclerotic lesion progression and neutrophilia in hypercholesterolemic mice
10.1371/journal.pone.0109416 · doi-reference
Six-of-the-best: unique contributions of γδ T cells to immunology
10.1038/nri3384 · doi-reference
Software survey: VOSviewer, a computer program for bibliometric mapping
10.1007/s11192-009-0146-3 · doi-reference
Human Vγ9/Vδ2 T cells: innate adaptors of the immune system
10.1016/j.cellimm.2015.01.008 · doi-reference
PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation
10.7326/m18-0850 · doi-reference
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
10.1056/nejmoa1200690 · doi-reference
Natural and synthetic non-peptide antigens recognized by human γδ T cells
10.1038/375155a0 · doi-reference
β-Catenin drives butyrophilin-like molecule loss and γδ T-cell exclusion in colon cancer
10.1158/2326-6066.cir-22-0644 · doi-reference
GMP-grade manufacturing of T cells engineered to express a defined γδTCR
10.3389/fimmu.2018.01062 · doi-reference
Dysfunctional tumor-infiltrating Vδ1+ T lymphocytes in microsatellite-stable colorectal cancer
10.1038/s41467-024-51025-1 · doi-reference
γδ T cells in cancer
10.1038/nri3904 · doi-reference
Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies
10.1038/s41573-019-0038-z · doi-reference
Management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy: ASCO guideline
10.1200/jco.21.01992 · doi-reference
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
10.3389/fimmu.2020.01347 · doi-reference
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
10.1126/science.aay5516 · doi-reference
Systematic analysis of human colorectal cancer scRNA-seq revealed limited pro-tumoral IL-17 production potential in gamma delta T cells
10.1016/j.neo.2024.101072 · doi-reference
Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes
10.1073/pnas.1818488116 · doi-reference
Human Vδ2 T cells are a major source of interleukin-9
10.1073/pnas.1607136113 · doi-reference
Function of γδ T cells in tumor immunology and their application to cancer therapy
10.1038/s12276-021-00576-0 · doi-reference
Allogeneic CD20-targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma models
10.1002/cti2.1373 · doi-reference
Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma
10.1056/nejmoa1707447 · doi-reference
Glucose metabolism controls human γδ T-cell-mediated tumor immunosurveillance in diabetes
10.1038/s41423-022-00894-x · doi-reference
The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness
10.1038/s41590-018-0253-5 · doi-reference
Phase I/II trial of LAVA-1207, a novel bispecific gamma-delta T-cell engager alone, or with low dose IL-2 or pembrolizumab, in metastatic castration resistant prostate cancer (mCRPC)
10.1200/jco.2024.42.16_suppl.tps2672 · doi-reference
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
10.1056/nejmoa1709866 · doi-reference
Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma
10.1136/jitc-2021-003441 · doi-reference
Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments
10.1038/s41590-020-00848-3 · doi-reference
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient
10.1038/s41467-024-45449-y · doi-reference
Scoping studies: advancing the methodology
10.1186/1748-5908-5-69 · doi-reference